Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K133856
    Manufacturer
    Date Cleared
    2014-01-16

    (28 days)

    Product Code
    Regulation Number
    880.5200
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    POWERGLIDE MIDLINE CATHETER

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The PowerGlide® Midline Catheter is intended to be inserted in the patient's vascular system for short term use (less than 30 days) to sample blood or administer fluids intravenously.
    The PowerGlide® Midline Catheter is inserted into a patient's vascular system for short-term use (

    Device Description

    Bard Access Systems, Inc.'s PowerGlide® Midline Catheter is a sterile, single use device designed to provide access to the patient's vascular system. The device is intended for short term use (

    AI/ML Overview

    The provided text does not contain information about an AI/ML device or a study proving its performance through clinical trials or a specific test set with ground truth established by experts.

    The document is a 510(k) summary for the PowerGlide® Midline Catheter, a medical device that received clearance in January 2014. This is a traditional medical device, not an AI/ML product.

    Therefore, I cannot provide the requested information regarding acceptance criteria, reported device performance, sample sizes for test and training sets, data provenance, number or qualifications of experts, adjudication methods, MRMC studies, standalone performance, or types of ground truth used, as these details are specific to the evaluation of AI/ML software.

    The document states that:

    • "Verification and validation activities were designed and performed in accordance with Design Controls as per 21 CFR §820.30."
    • Various guidance documents and standards were used to determine appropriate evaluation methods (listed in section {2}).
    • "The subject device met all predetermined acceptance criteria derived from the above listed references and demonstrated substantially equivalent performance as compared to the cited predicate device."
    • Substantial equivalence was determined "Based on the indications for use, technological characteristics, and safety and performance testing".

    This indicates that the device met pre-defined engineering and performance specifications based on established medical device standards and comparisons to a predicate device (K121073), which is the standard pathway for 510(k) clearance of non-AI/ML devices. There is no information about a "study that proves the device meets the acceptance criteria" in the context of an AI/ML product's performance evaluation.

    Ask a Question

    Ask a specific question about this device

    K Number
    K121073
    Manufacturer
    Date Cleared
    2012-06-01

    (53 days)

    Product Code
    Regulation Number
    880.5200
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    POWERGLIDE MIDLINE CATHETER

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The PowerGlide™ Midline Catheter is intended to be inserted in the patient's vascular system for short term use (less than 30 days) to sample blood or administer fluids intravenously.

    The PowerGlide™ Midline Catheter is inserted into a patient's vascular system for short-term use (

    Device Description

    Bard Access Systems, Inc.'s PowerGlide™ Midline Catheter is a sterile, single use device designed to provide access to the patient's vascular system. The device is intended for short term use (

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and study information for the PowerGlide™ Midline Catheter, based on the provided document:

    1. Table of Acceptance Criteria and Reported Device Performance

    The provided document describes the safety and performance testing for the PowerGlide™ Midline Catheter. It states that the device "met all predetermined acceptance criteria derived from the above listed references and demonstrated substantially equivalent performance as compared to the cited predicate devices." However, it does not provide a specific table with numerical acceptance criteria and corresponding device performance values. Instead, it refers to compliance with various industry standards and guidance documents.

    Here's a summary of the areas of performance verification mentioned:

    Acceptance Criteria Area (Implied from References)Reported Device Performance
    General Catheter Requirements: (from ISO 10555-1, ISO 10555-5)- The device met predetermined acceptance criteria for general requirements of sterile, single-use intravascular catheters.
    Intravascular Catheter Introducer Requirements: (from ISO 11070)- The device met predetermined acceptance criteria for sterile, single-use intravascular catheter introducers.
    Guidewire Requirements: (from Coronary and Cerebrovascular Guidewire Guidance)- The device met predetermined acceptance criteria for guidewire performance.
    Luer Taper Fittings Requirements: (from ISO 594-1, ISO 594-2)- The device met predetermined acceptance criteria for conical luer taper fittings.
    Hypodermic Needles Requirements: (from ISO 9626, ISO 7864)- The device met predetermined acceptance criteria for stainless steel needle tubing and sterile hypodermic needles for single use.
    Sharps Injury Protection Features: (from ISO 23908, FDA Guidance: Medical Devices with Sharps Injury Prevention Features, BS 7320)- The device met predetermined acceptance criteria for sharps injury protection features. The device description mentions a "passive safety mechanism" for the introducer needle.
    Biocompatibility: (from AAMI/ANSI/ISO 10993-1, AAMI/ANSI/ISO 10993-7, #G95-1)- The device met predetermined acceptance criteria for biological evaluation and ethylene oxide sterilization residuals.
    Sterilization: (from AAMI/ANSI/ISO 11135)- The device met predetermined acceptance criteria for ethylene oxide sterilization validation and routine control.
    Radiopacity: (from ASTM F640-79)- The device met predetermined acceptance criteria for radiopacity.
    Risk Management: (from ISO 14971)- A Failure Modes and Effects Analysis (FMEA) was conducted, and the device met predetermined acceptance criteria for risk management.
    Overall Safety & Effectiveness / Substantial Equivalence:- The device met the requirements considered sufficient for its intended use and is as safe and as effective as the cited predicate devices.

    2. Sample Size for the Test Set and Data Provenance

    The document does not explicitly state the sample size used for the test set for performance validation studies. It only mentions that "Verification and validation tests have been performed in accordance with Design Controls as per 21 CFR §820.30."

    The data provenance (country of origin, retrospective/prospective) is also not mentioned. The testing appears to be primarily bench testing and in-house validation based on compliance with international standards, rather than clinical data from human subjects.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of Experts

    This information is not provided in the document. Given that the testing appears to be primarily bench and laboratory-based, the concept of "experts establishing ground truth for a test set" in a clinical sense (e.g., radiologist consensus) does not directly apply here. Performance was likely evaluated against engineering specifications derived from the referenced standards.

    4. Adjudication Method for the Test Set

    This information is not applicable and not specified. Adjudication methods are typically used in clinical studies where multiple reviewers interpret data, which is not described here.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was Done

    No, a Multi Reader Multi Case (MRMC) comparative effectiveness study was not done. The document describes engineering and biocompatibility testing for substantial equivalence, not a clinical trial comparing human reader performance.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was Done

    This question is not applicable as the device is a physical medical catheter, not an AI algorithm.

    7. The Type of Ground Truth Used

    The "ground truth" for the performance of the PowerGlide™ Midline Catheter was established through compliance with recognized international and national standards and guidance documents. These standards define measurable requirements (e.g., material properties, dimensional tolerances, flow rates, tensile strength, biocompatibility limits, sterilization efficacy, luer connection integrity, sharps protection effectiveness). The device's performance was measured against these predefined specifications.

    8. The Sample Size for the Training Set

    This question is not applicable as the device is a physical medical catheter, not an AI algorithm. There is no "training set."

    9. How the Ground Truth for the Training Set Was Established

    This question is not applicable as the device is a physical medical catheter, not an AI algorithm. There is no "training set" or corresponding ground truth establishment for it.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1